Idursulfase
Pharmaceutical compound
From Wikipedia, the free encyclopedia
Idursulfase (brand name Elaprase), manufactured by Takeda, is a drug used to treat Hunter syndrome (also called MPS-II).[1] It is a purified form of iduronate-2-sulfatase, a lysosomal enzyme, and is produced by recombinant DNA technology in a human cell line.
| Clinical data | |
|---|---|
| AHFS/Drugs.com | Monograph |
| License data | |
| ATC code | |
| Identifiers | |
| CAS Number | |
| DrugBank | |
| ChemSpider |
|
| UNII | |
| KEGG | |
| ChEMBL | |
  (what is this?) (verify) | |
It is one of the most expensive drugs ever produced, costing US$567,412 per patient per year.[2][3][4]
